Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults

Floris P. Barthel, Kevin C. Johnson, Pieter Wesseling, Roel G. W. Verhaak

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Recent advances in molecular analysis and genome sequencing have prompted a paradigm shift in neuropathology. This article discusses the discovery and clinical relevance of molecular biomarkers in diffuse gliomas in adults and how these biomarkers led to revision of the World Health Organization classification of these tumors. We relate progress in clinical classification to an overview of studies using molecular profiling to study gene expression and DNA methylation to categorize diffuse gliomas in adults and issues dealing with intratumoral heterogeneity. These efforts will refine the taxonomy of diffuse gliomas, facilitate selection of appropriate treatment regimens, and ultimately improve patient's lives.
Original languageEnglish
Pages (from-to)421-437
JournalNeurologic Clinics
Volume36
Issue number3
DOIs
Publication statusPublished - 2018

Cite this

Barthel, Floris P. ; Johnson, Kevin C. ; Wesseling, Pieter ; Verhaak, Roel G. W. / Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults. In: Neurologic Clinics. 2018 ; Vol. 36, No. 3. pp. 421-437.
@article{f10a32863fe446138b0b881d8da3bbf4,
title = "Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults",
abstract = "Recent advances in molecular analysis and genome sequencing have prompted a paradigm shift in neuropathology. This article discusses the discovery and clinical relevance of molecular biomarkers in diffuse gliomas in adults and how these biomarkers led to revision of the World Health Organization classification of these tumors. We relate progress in clinical classification to an overview of studies using molecular profiling to study gene expression and DNA methylation to categorize diffuse gliomas in adults and issues dealing with intratumoral heterogeneity. These efforts will refine the taxonomy of diffuse gliomas, facilitate selection of appropriate treatment regimens, and ultimately improve patient's lives.",
author = "Barthel, {Floris P.} and Johnson, {Kevin C.} and Pieter Wesseling and Verhaak, {Roel G. W.}",
year = "2018",
doi = "10.1016/j.ncl.2018.04.002",
language = "English",
volume = "36",
pages = "421--437",
journal = "Neurologic Clinics",
issn = "0733-8619",
publisher = "W.B. Saunders Ltd",
number = "3",

}

Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults. / Barthel, Floris P.; Johnson, Kevin C.; Wesseling, Pieter; Verhaak, Roel G. W.

In: Neurologic Clinics, Vol. 36, No. 3, 2018, p. 421-437.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults

AU - Barthel, Floris P.

AU - Johnson, Kevin C.

AU - Wesseling, Pieter

AU - Verhaak, Roel G. W.

PY - 2018

Y1 - 2018

N2 - Recent advances in molecular analysis and genome sequencing have prompted a paradigm shift in neuropathology. This article discusses the discovery and clinical relevance of molecular biomarkers in diffuse gliomas in adults and how these biomarkers led to revision of the World Health Organization classification of these tumors. We relate progress in clinical classification to an overview of studies using molecular profiling to study gene expression and DNA methylation to categorize diffuse gliomas in adults and issues dealing with intratumoral heterogeneity. These efforts will refine the taxonomy of diffuse gliomas, facilitate selection of appropriate treatment regimens, and ultimately improve patient's lives.

AB - Recent advances in molecular analysis and genome sequencing have prompted a paradigm shift in neuropathology. This article discusses the discovery and clinical relevance of molecular biomarkers in diffuse gliomas in adults and how these biomarkers led to revision of the World Health Organization classification of these tumors. We relate progress in clinical classification to an overview of studies using molecular profiling to study gene expression and DNA methylation to categorize diffuse gliomas in adults and issues dealing with intratumoral heterogeneity. These efforts will refine the taxonomy of diffuse gliomas, facilitate selection of appropriate treatment regimens, and ultimately improve patient's lives.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85050664447&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30072063

U2 - 10.1016/j.ncl.2018.04.002

DO - 10.1016/j.ncl.2018.04.002

M3 - Review article

VL - 36

SP - 421

EP - 437

JO - Neurologic Clinics

JF - Neurologic Clinics

SN - 0733-8619

IS - 3

ER -